Blood Cancer News and Research

RSS
T-cells play key role in how the body fights follicular lymphoma

T-cells play key role in how the body fights follicular lymphoma

Study discovers new therapy for aggressive blood cancer

Study discovers new therapy for aggressive blood cancer

Study: Diagnosis delays for patients with lymphoma could be avoided

Study: Diagnosis delays for patients with lymphoma could be avoided

New drug compounds show promise in treating acute myeloid leukemia

New drug compounds show promise in treating acute myeloid leukemia

Study: Prolonged presence of precursor cells in thymus may give rise to leukemia

Study: Prolonged presence of precursor cells in thymus may give rise to leukemia

Researchers discover mechanism which drives leukemia cell growth

Researchers discover mechanism which drives leukemia cell growth

Active ingredient in eye drops shows promise for treating aggressive blood cancer

Active ingredient in eye drops shows promise for treating aggressive blood cancer

Research advances offer hope for patient-tailored AML treatment

Research advances offer hope for patient-tailored AML treatment

New technology for profiling genetic makeup of myeloma tumor cells developed

New technology for profiling genetic makeup of myeloma tumor cells developed

Financial difficulties add to patients' cancer struggle

Financial difficulties add to patients' cancer struggle

UK scientists find new way to identify patients with aggressive lymphoma

UK scientists find new way to identify patients with aggressive lymphoma

Study: 51% of patients alive two years after receiving CAR-T therapy for diffuse large B-cell lymphoma

Study: 51% of patients alive two years after receiving CAR-T therapy for diffuse large B-cell lymphoma

FDA approves new combination therapy for acute myeloid leukemia

FDA approves new combination therapy for acute myeloid leukemia

Researchers identify inconspicuous protein as key to aggressive blood cancer

Researchers identify inconspicuous protein as key to aggressive blood cancer

Abramson Cancer Center becomes the 28th member institution of National Comprehensive Cancer Network

Abramson Cancer Center becomes the 28th member institution of National Comprehensive Cancer Network

Phase III CLL14 study evaluating Venclexta plus Gazyva to treat CLL meets its primary endpoint

Phase III CLL14 study evaluating Venclexta plus Gazyva to treat CLL meets its primary endpoint

Researchers uncover link between RNA abnormalities and multiple myeloma progression

Researchers uncover link between RNA abnormalities and multiple myeloma progression

Ten Allen Distinguished Investigators for 2018 announced by Paul G. Allen Frontiers Group

Ten Allen Distinguished Investigators for 2018 announced by Paul G. Allen Frontiers Group

Study suggests new strategy to kill melanoma cells

Study suggests new strategy to kill melanoma cells

Researchers develop promising targeted strategy to treat chemo-resistant blood cancer

Researchers develop promising targeted strategy to treat chemo-resistant blood cancer